SpyGlass Pharma Financials - Benzinga

SpyGlass Pharma Inc

SGPNASDAQ

Trade with Public

Trade with Public

$26.60

Last update: Aug 25, 4:00 PM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

SpyGlass Pharma Financials

SpyGlass Pharma (SGP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
SpyGlass Pharma Q1 EPS $(0.69) Misses $(0.42) Estimate

SpyGlass Pharma (NASDAQ:SGP) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.42) by 64.29 percent. This is a 82.58 percent increase over losses of $(3.96) per share from

Benzinga Newsdesk

PRO
SpyGlass Pharma Q4 EPS $(5.72) Down From $(4.58) YoY

SpyGlass Pharma (NASDAQ:SGP) reported quarterly losses of $(5.72) per share. This is a 24.89 percent decrease over losses of $(4.58) per share from the same period last year.

Benzinga Newsdesk